NTHI
NEONC TECHNOLOGIES HOLDINGS, INC.
NASDAQ · Healthcare · Biotechnology · US
$2.72
+0.74%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.25
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.58
- EPS estimate
- -$0.12
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -123.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $18
- PT range
- $15 – $20
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.12 | -$0.58 | Miss -397.13% | — |
| May 18, 2026 | -$0.22 | -$0.38 | Miss -73.52% | — |
| Mar 31, 2026 | -$0.37 | -$0.37 | In line | — |
| Nov 14, 2025 | -$0.37 | -$0.45 | Miss -21.62% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026